(TILE) Interface - Overview
Stock: Carpet, Vinyl, Rubber, Installation, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.24% |
| Yield on Cost 5y | 0.52% |
| Yield CAGR 5y | 10.67% |
| Payout Consistency | 79.4% |
| Payout Ratio | 4.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.3% |
| Relative Tail Risk | -12.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.08 |
| Alpha | 32.32 |
| Character TTM | |
|---|---|
| Beta | 0.909 |
| Beta Downside | 0.630 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.01% |
| CAGR/Max DD | 1.06 |
Description: TILE Interface January 15, 2026
Interface, Inc. (NASDAQ:TILE) designs, manufactures, and distributes modular carpet and resilient flooring solutions across North America, Europe, Asia, Africa, and Latin America, serving commercial interiors such as offices, schools, hospitals, airports, hotels, retail, and residential projects. The product portfolio includes carpet tiles, luxury vinyl tiles, rubber flooring, and related installation systems (e.g., TacTiles), with sales channeled through direct accounts and a network of independent contractors, installers, and distributors under the Interface, FLOR, noraplan, and noramen brands.
Recent financial snapshots (FY 2023) show revenue of roughly $1.33 billion, a year-over-year growth of 4.2%, and an adjusted EBITDA margin near 12%, reflecting steady demand for durable, design-flexible flooring amid a recovering commercial-real-estate market. The company’s sustainability agenda-targeting net-zero carbon emissions by 2040-has become a material driver of client preference, especially in green-certified construction projects.
Key sector dynamics include a modest rebound in office vacancy rates (U.S. office vacancy fell to ~16% in Q4 2023 from a peak of ~19% in 2022) and continued strength in the resilient-flooring segment, which is projected to grow at a CAGR of ~5% through 2028 due to higher traffic-heavy usage and lower life-cycle costs versus traditional carpet.
For a deeper dive into Interface’s valuation metrics, you might find ValueRay’s analyst notes useful.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 113.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.04 > 1.0 |
| NWC/Revenue: 33.14% < 20% (prev 28.47%; Δ 4.67% < -1%) |
| CFO/TA 0.12 > 3% & CFO 156.6m > Net Income 113.5m |
| Net Debt (202.7m) to EBITDA (198.4m): 1.02 < 3 |
| Current Ratio: 2.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.2m) vs 12m ago 0.51% < -2% |
| Gross Margin: 38.24% > 18% (prev 0.37%; Δ 3787 % > 0.5%) |
| Asset Turnover: 106.6% > 50% (prev 105.0%; Δ 1.62% > 0%) |
| Interest Coverage Ratio: 8.64 > 6 (EBITDA TTM 198.4m / Interest Expense TTM 18.0m) |
Altman Z'' 2.71
| A: 0.34 (Total Current Assets 695.1m - Total Current Liabilities 240.2m) / Total Assets 1.33b |
| B: 0.00 (Retained Earnings 5.84m / Total Assets 1.33b) |
| C: 0.12 (EBIT TTM 155.1m / Avg Total Assets 1.29b) |
| D: -0.34 (Book Value of Equity -244.1m / Total Liabilities 709.6m) |
| Altman-Z'' Score: 2.71 = A |
Beneish M -3.08
| DSRI: 1.02 (Receivables 187.1m/173.9m, Revenue 1.37b/1.31b) |
| GMI: 0.97 (GM 38.24% / 37.05%) |
| AQI: 0.92 (AQ_t 0.20 / AQ_t-1 0.22) |
| SGI: 1.05 (Revenue 1.37b / 1.31b) |
| TATA: -0.03 (NI 113.5m - CFO 156.6m) / TA 1.33b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of TILE shares?
Over the past week, the price has changed by +10.04%, over one month by +17.91%, over three months by +34.43% and over the past year by +47.29%.
Is TILE a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TILE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.3 | 4.9% |
| Analysts Target Price | 36.3 | 4.9% |
| ValueRay Target Price | 44.9 | 29.7% |
TILE Fundamental Data Overview February 03, 2026
P/E Forward = 15.8479
P/S = 1.3389
P/B = 2.9583
P/EG = 1.0566
Revenue TTM = 1.37b USD
EBIT TTM = 155.1m USD
EBITDA TTM = 198.4m USD
Long Term Debt = 307.3m USD (from longTermDebt, last quarter)
Short Term Debt = 14.1m USD (from shortTermDebt, last quarter)
Debt = 390.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 202.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.04b USD (1.84b + Debt 390.0m - CCE 187.4m)
Interest Coverage Ratio = 8.64 (Ebit TTM 155.1m / Interest Expense TTM 18.0m)
EV/FCF = 17.37x (Enterprise Value 2.04b / FCF TTM 117.5m)
FCF Yield = 5.76% (FCF TTM 117.5m / Enterprise Value 2.04b)
FCF Margin = 8.56% (FCF TTM 117.5m / Revenue TTM 1.37b)
Net Margin = 8.27% (Net Income TTM 113.5m / Revenue TTM 1.37b)
Gross Margin = 38.24% ((Revenue TTM 1.37b - Cost of Revenue TTM 847.6m) / Revenue TTM)
Gross Margin QoQ = 39.40% (prev 39.41%)
Tobins Q-Ratio = 1.53 (Enterprise Value 2.04b / Total Assets 1.33b)
Interest Expense / Debt = 1.08% (Interest Expense 4.21m / Debt 390.0m)
Taxrate = 4.83% (2.34m / 48.5m)
NOPAT = 147.6m (EBIT 155.1m * (1 - 4.83%))
Current Ratio = 2.89 (Total Current Assets 695.1m / Total Current Liabilities 240.2m)
Debt / Equity = 0.63 (Debt 390.0m / totalStockholderEquity, last quarter 621.0m)
Debt / EBITDA = 1.02 (Net Debt 202.7m / EBITDA 198.4m)
Debt / FCF = 1.73 (Net Debt 202.7m / FCF TTM 117.5m)
Total Stockholder Equity = 549.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.82% (Net Income 113.5m / Total Assets 1.33b)
RoE = 20.65% (Net Income TTM 113.5m / Total Stockholder Equity 549.5m)
RoCE = 18.10% (EBIT 155.1m / Capital Employed (Equity 549.5m + L.T.Debt 307.3m))
RoIC = 17.28% (NOPAT 147.6m / Invested Capital 854.0m)
WACC = 7.82% (E(1.84b)/V(2.23b) * Re(9.26%) + D(390.0m)/V(2.23b) * Rd(1.08%) * (1-Tc(0.05)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.46%
[DCF Debug] Terminal Value 81.42% ; FCFF base≈114.2m ; Y1≈136.4m ; Y5≈215.7m
Fair Price DCF = 61.69 (EV 3.80b - Net Debt 202.7m = Equity 3.60b / Shares 58.4m; r=7.82% [WACC]; 5y FCF grow 20.77% → 2.90% )
EPS Correlation: 20.07 | EPS CAGR: -46.14% | SUE: -4.0 | # QB: 0
Revenue Correlation: 31.81 | Revenue CAGR: 1.90% | SUE: 0.72 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.27 | Chg30d=-0.007 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=2.02 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+8.8% | Growth Revenue=+4.8%